Skip to main content
. 2012 Jul 18;6:1113–1124. doi: 10.2147/OPTH.S32643

Figure 3.

Figure 3

Mean +/− standard deviation change from baseline in anterior chamber cell and flare severity, individually and combined, for the loteprednol etabonate (LE) gel and vehicle groups (intention-to-treat population).

Notes: Negative values denote an improvement. *(P ≤ 0.002).